The Scientist

» neurodegenerative diseases

Most Recent

image: How Microbes May Influence Our Behavior

How Microbes May Influence Our Behavior

By | September 1, 2017

Researchers are piecing together the links between the gut microbiome and mental health.

1 Comment

image: Do Microbes Trigger Alzheimer’s Disease?

Do Microbes Trigger Alzheimer’s Disease?

By | September 1, 2017

The once fringe idea is gaining traction among the scientific community.

6 Comments

Emerging evidence links bacterial or viral infection with the neuropathology of Alzheimer’s disease.

0 Comments

Neurons derived from human induced pluripotent stem cells fill in for lost dopamine neurons in a primate model of the disease.

0 Comments

image: A Potential Remedy for the Aging Brain

A Potential Remedy for the Aging Brain

By | August 8, 2017

In mice, injected fragments of a naturally occurring protein boost memory in young and old animals and improve cognition and mobility in a model of neurodegenerative disease. 

0 Comments

image: Second-Ever ALS Drug Approved

Second-Ever ALS Drug Approved

By | May 8, 2017

Amyotrophic lateral sclerosis patients in the U.S. now have an option besides riluzole, which was approved by the FDA more than two decades ago and only extends life by two or three months.

1 Comment

image: Opinion: Canine Models for Alzheimer’s

Opinion: Canine Models for Alzheimer’s

By | March 1, 2017

For research on drugs to treat neurodegenerative diseases, dogs offer a better predictor of clinical outcomes. 

7 Comments

image: FDA Approves First Treatment for Spinal Muscular Atrophy

FDA Approves First Treatment for Spinal Muscular Atrophy

By | December 28, 2016

The oligonucleotide therapeutic will soon be available in the U.S.

0 Comments

image: Gut Microbes Linked to Neurodegenerative Disease

Gut Microbes Linked to Neurodegenerative Disease

By | December 1, 2016

Bacteria in the intestine influence motor dysfunction and neuroinflammation in a mouse model of Parkinson’s disease.

3 Comments

image: New Support for Experimental Alzheimer’s Drug

New Support for Experimental Alzheimer’s Drug

By | November 2, 2016

Merck’s verubecestat, which is currently being tested in two Phase 3 studies, is safe, according to newly published Phase 1 data.

2 Comments

Popular Now

  1. Decoding the Tripping Brain
  2. Tattoo Ink Nanoparticles Persist in Lymph Nodes
    The Nutshell Tattoo Ink Nanoparticles Persist in Lymph Nodes

    Analysis of the bodies of deceased individuals can’t determine what effect these tattoo remnants have on lymph function, but researchers suggest dirty needles aren’t the only risk of the age-old practice.

  3. Do Microbes Trigger Alzheimer’s Disease?
  4. Metabolomics Data Under Scrutiny
    Daily News Metabolomics Data Under Scrutiny

    Out of 25,000 features originally detected by metabolic profiling of E. coli, fewer than 1,000 represent unique metabolites, a study finds.

AAAS